| Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research AIR Maas, DK Menon, PD Adelson, N Andelic, MJ Bell, A Belli, P Bragge, ... The Lancet Neurology 16 (12), 987-1048, 2017 | 2052 | 2017 |
| Critically ill patients with 2009 influenza A (H1N1) infection in Canada A Kumar, R Zarychanski, R Pinto, DJ Cook, J Marshall, J Lacroix, T Stelfox, ... Jama 302 (17), 1872-1879, 2009 | 2010 | 2009 |
| Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis M Briel, M Meade, A Mercat, RG Brower, D Talmor, SD Walter, AS Slutsky, ... Jama 303 (9), 865-873, 2010 | 1795 | 2010 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report Remap-Cap Investigators, AC Gordon, PR Mouncey, F Al-Beidh, ... Medrxiv, 2021.01. 07.21249390, 2021 | 1310 | 2021 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1016 | 2021 |
| High-frequency oscillation in early acute respiratory distress syndrome ND Ferguson, DJ Cook, GH Guyatt, S Mehta, L Hand, P Austin, Q Zhou, ... New England Journal of Medicine 368 (9), 795-805, 2013 | 978 | 2013 |
| A living WHO guideline on drugs for covid-19 A Agarwal, B Rochwerg, F Lamontagne, RAC Siemieniuk, T Agoritsas, ... | 941 | 2022 |
| Drug treatments for covid-19: living systematic review and network meta-analysis RAC Siemieniuk, JJ Bartoszko, D Zeraatkar, E Kum, A Qasim, ... bmj 370, 2020 | 927 | 2020 |
| Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020 | 816 | 2020 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 599 | 2021 |
| Failure to engage hospitalized elderly patients and their families in advance care planning DK Heyland, D Barwich, D Pichora, P Dodek, F Lamontagne, JJ You, ... JAMA internal medicine 173 (9), 778-787, 2013 | 581 | 2013 |
| Clinical presentation of patients with Ebola virus disease in Conakry, Guinea EI Bah, MC Lamah, T Fletcher, ST Jacob, DM Brett-Major, AA Sall, ... New England Journal of Medicine 372 (1), 40-47, 2015 | 496 | 2015 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 470 | 2021 |
| Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain F Lamontagne, AC Labbé, O Haeck, O Lesur, M Lalancette, C Patino, ... Annals of surgery 245 (2), 267-272, 2007 | 446 | 2007 |
| Barriers to goals of care discussions with seriously ill hospitalized patients and their families: a multicenter survey of clinicians JJ You, J Downar, RA Fowler, F Lamontagne, IWY Ma, D Jayaraman, ... JAMA internal medicine 175 (4), 549-556, 2015 | 412 | 2015 |
| One-year outcomes in caregivers of critically ill patients JI Cameron, LM Chu, A Matte, G Tomlinson, L Chan, C Thomas, ... New England Journal of Medicine 374 (19), 1831-1841, 2016 | 379 | 2016 |
| The RECOVER program: disability risk groups and 1-year outcome after 7 or more days of mechanical ventilation MS Herridge, LM Chu, A Matte, G Tomlinson, L Chan, C Thomas, ... American journal of respiratory and critical care medicine 194 (7), 831-844, 2016 | 374 | 2016 |
| Prevalence, characteristics, and publication of discontinued randomized trials B Kasenda, E Von Elm, J You, A Blümle, Y Tomonaga, R Saccilotto, ... Jama 311 (10), 1045-1052, 2014 | 349 | 2014 |
| Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review EA Akl, M Briel, JJ You, X Sun, BC Johnston, JW Busse, S Mulla, ... Bmj 344, 2012 | 325 | 2012 |
| The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. Rationale and design DC Angus, S Berry, RJ Lewis, F Al-Beidh, Y Arabi, W van Bentum-Puijk, ... Annals of the American Thoracic Society 17 (7), 879-891, 2020 | 296 | 2020 |
